BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update

—Q2 2025 ORLADEYO net revenue of $156.8 million (+45 percent y-o-y)—

—Q2 2025 operating profit of $29.8 million (+239 percent y-o-y); non-GAAP operating profit of $57.0 million (+160 percent y-o-y)—

Read more at globenewswire.com